Experimental eye implant aims to halt vision loss in dry AMD
Disease control
Recruiting now
This Phase IIb trial tests a retinal implant (CPCB-RPE1) in 24 people with advanced dry age-related macular degeneration (geographic atrophy). Participants are randomly assigned to receive the implant or a sham procedure. The study measures changes in retinal sensitivity and visu…
Phase: PHASE2 • Sponsor: Regenerative Patch Technologies, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC